skip to main content

S.Res. 165 (114th): A resolution supporting the goals and ideals of World Malaria Day.

The text of the bill below is as of Apr 30, 2015 (Resolution Agreed to by Senate).


III

114th CONGRESS

1st Session

S. RES. 165

IN THE SENATE OF THE UNITED STATES

April 30, 2015

(for himself, Mr. Coons, Mr. Durbin, Mr. Inhofe, Mr. Boozman, Mr. Rubio, Mr. Cochran, Mrs. Boxer, Mr. Kirk, Mr. Cardin, and Mr. Brown) submitted the following resolution; which was considered and agreed to

RESOLUTION

Supporting the goals and ideals of World Malaria Day.

Whereas April 25th of each year is recognized internationally as World Malaria Day;

Whereas malaria is a leading cause of death and disease in many developing countries, despite being preventable and treatable;

Whereas fighting malaria is in the national interest of the United States, as reducing the risk of malaria protects members of the Armed Forces of the United States and other people of the United States serving overseas in malaria-endemic regions, and reducing malaria deaths helps to lower risks of instability in less developed countries;

Whereas support for efforts to fight malaria is in the diplomatic and moral interest of the United States, as that support generates goodwill toward the United States and highlights the values of the people of the United States through the work of governmental, nongovernmental, and faith-based organizations of the United States;

Whereas efforts to fight malaria are in the long-term economic interest of the United States because those efforts help developing countries—

(1)

identify at-risk populations;

(2)

provide a framework for critical emergency disease treatment;

(3)

provide better health services;

(4)

increase local governance needed to address substandard and counterfeit medicines that exacerbate malaria resistance;

(5)

produce healthier and more productive workforces;

(6)

advance economic development; and

(7)

promote stronger trading partners;

Whereas malaria transmission occurred in 97 countries and territories in 2014, and an estimated 3,200,000,000 people are at risk for malaria, the majority of whom are in sub-Saharan Africa, which accounts for 90 percent of malaria deaths in the world;

Whereas young children and pregnant women are particularly vulnerable to and disproportionately affected by malaria;

Whereas malaria greatly affects the health of children, as children under the age of 5 account for an estimated 78 percent of malaria deaths each year;

Whereas malaria poses great risks to maternal and neonatal health, causing complications during delivery, anemia, and low birth weights, and estimates indicate that malaria infection causes approximately 400,000 cases of severe maternal anemia and between 75,000 and 200,000 infant deaths annually in sub-Saharan Africa;

Whereas heightened national, regional, and international efforts to prevent and treat malaria during recent years have made significant progress and helped save hundreds of thousands of lives;

Whereas the World Malaria Report 2014 by the World Health Organization states that in 2013, approximately 49 percent of households in sub-Saharan Africa owned at least one insecticide-treated mosquito net, and household surveys indicated that 90 percent of people used an insecticide-treated mosquito net if one was available in the household;

Whereas, in 2013, approximately 123,000,000 people were protected by indoor residual spraying;

Whereas the World Malaria Report 2014 further states that between 2000 and 2013—

(1)

malaria mortality rates decreased by 47 percent around the world;

(2)

in the African Region of the World Health Organization, malaria mortality rates decreased by 54 percent; and

(3)

an estimated 4,300,000 malaria deaths were averted globally, primarily as a result of increased interventions;

Whereas the World Malaria Report 2014 further states that out of 97 countries with ongoing transmission of malaria in 2014—

(1)

10 countries are classified as being in the pre-elimination phase;

(2)

9 countries are classified as being in the elimination phase; and

(3)

7 countries are classified as being in the prevention of malaria reintroduction phase of malaria control;

Whereas continued national, regional, and international investment in efforts to eliminate malaria, including prevention and treatment efforts, the development of a vaccine to immunize children from the malaria parasite, and advancements in insecticides, are critical in order to continue to reduce malaria deaths, prevent backsliding in areas where progress has been made, and equip the United States and the global community with the tools necessary to fight malaria and other global health threats;

Whereas the United States Government has played a leading role in the recent progress made toward reducing the global burden of malaria, particularly through the President’s Malaria Initiative (referred to in this preamble as the PMI) and the contribution of the United States to the Global Fund to Fight AIDS, Tuberculosis, and Malaria;

Whereas, in May 2011, an independent, external evaluation, prepared by Boston University, examining 6 objectives of the PMI, found the PMI to be a successful, well-led program that has earned and deserves the task of sustaining and expanding the United States Government’s response to global malaria control efforts;

Whereas the United States Government is pursuing a comprehensive approach to ending malaria deaths through the PMI, which is led by the United States Agency for International Development and implemented with assistance from the Centers for Disease Control and Prevention, the Department of State, the Department of Health and Human Services, the National Institutes of Health, the Department of Defense, and private sector entities;

Whereas the PMI focuses on helping partner countries achieve major improvements in overall health outcomes through improved access to, and quality of, healthcare services in locations with limited resources; and

Whereas the PMI, recognizing the burden of malaria on many partner countries, has set a target by 2020 of reducing malaria mortality by 1/3 from 2015 levels in PMI-supported countries, achieving a greater than 80 percent reduction from original 2000 baseline levels set by the PMI, reducing malaria morbidity in PMI-supported countries by 40 percent from 2015 levels, and assisting at least 5 PMI-supported countries to meet the criteria of the World Health Organization for national or sub-national pre-elimination: Now, therefore, be it

That the Senate—

(1)

supports the goals and ideals of World Malaria Day;

(2)

recognizes the importance of reducing malaria prevalence and deaths to improve overall child and maternal health, especially in sub-Saharan Africa;

(3)

commends the recent progress made toward reducing global malaria morbidity, mortality, and prevalence, particularly through the efforts of the President’s Malaria Initiative and the Global Fund to Fight AIDS, Tuberculosis, and Malaria;

(4)

welcomes ongoing public-private partnerships to research and develop more effective and affordable tools for malaria diagnosis, treatment, and vaccination;

(5)

recognizes the goals, priorities, and authorities to combat malaria set forth in the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (Public Law 110–293; 122 Stat. 2918);

(6)

supports continued leadership by the United States in bilateral, multilateral, and private sector efforts to combat malaria and to work with developing countries to create long-term strategies to increase ownership over malaria programs; and

(7)

encourages other members of the international community to sustain and increase their support for and financial contributions to efforts to combat malaria worldwide.